IL‐33/ST2 as a potential target for tumor immunotherapy-Reference-Cited by-同舟云学术

IL‐33/ST2 as a potential target for tumor immunotherapy

Published:2021-06-23 Issue:8 Volume:51 Page:1943-1955
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Jiang Wenyi¹²,Lian Jingyao¹²,Yue Ying³,Zhang Yi¹²⁴^ORCID

Affiliation:

1. Biotherapy Center and Cancer Center The First Affiliated Hospital of Zhengzhou University Zhengzhou Henan China

2. State Key Laboratory of Esophageal Cancer Prevention & Treatment Zhengzhou Henan China

3. Clinical Laboratory Henan Medical College Hospital Workers Zhengzhou Henan China

4. Henan Key Laboratory for Tumor Immunology and Biotherapy Zhengzhou Henan China

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/eji.202149175

Reference120 articles.

1. Fibroblast‐derived IL‐33 is dispensable for lymph node homeostasis but critical for CD8 T‐cell responses to acute and chronic viral infection;Aparicio‐Domingo P.;Eur. J. Immunol.,2020

2. Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family

3. Transcriptional Regulation of Murine IL-33 by TLR and Non-TLR Agonists

4. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system

5. IL-1 Receptor Accessory Protein and ST2 Comprise the IL-33 Receptor Complex

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting IL-33 reprograms the tumor microenvironment and potentiates antitumor response to anti-PD-L1 immunotherapy;Journal for ImmunoTherapy of Cancer;2024-09

2. Blocking IL-33 decelerates cartilage degeneration in knee osteoarthritis through mice model;PLOS ONE;2024-08-22

3. Inflammation accelerating intestinal fibrosis: from mechanism to clinic;European Journal of Medical Research;2024-06-18

4. Unveiling the multifaceted antitumor effects of interleukin 33;Frontiers in Immunology;2024-05-31

5. IL-33/NF-κB/ST2L/Rab37 positive-feedback loop promotes M2 macrophage to limit chemotherapeutic efficacy in lung cancer;Cell Death & Disease;2024-05-22